3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
19
Ovarian Neoplasms
17
Neuroblastoma
15
Fallopian Tube Neoplasms
13
Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Ganglioneuroblastoma
5
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Recurrence
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Glioma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Retinoblastoma
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC, Extensive Stage
1
SCLC
1
Rhabdomyosarcoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Interventions
Temozolomide
18
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Radiotherapy
13
Radiation
9
Biopsy
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Bevacizumab
4
vorasidenib
3
trametinib
3
Surgical Procedures, Operative
3
Spinal Puncture
3
tovorafenib
2
dabrafenib
2
Restraint, Physical
2
Leukapheresis
2
Ipilimumab
2
Genetic Therapy
2
Fluorodeoxyglucose F18
2
Eflornithine
2
Craniotomy
2
Carboplatin
2
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Topotecan
×
1 year
×
Clear all
No trials found.